Bacigalupo, A <br/><br/>
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.  [electronic resource] 

 -  Blood  Jul 1996 
 - 353-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow--drug effects<br/>Bone Marrow Diseases--chemically induced<br/>Bone Marrow Transplantation<br/>CD4 Lymphocyte Count<br/>Cause of Death<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Feasibility Studies<br/>Female<br/>Follow-Up Studies<br/>Graft Survival<br/>Graft vs Host Disease--etiology<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Infections--etiology<br/>Leukapheresis--adverse effects<br/>Leukemia--blood<br/>Lymphoma--blood<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--blood<br/>Multiple Organ Failure--etiology<br/>Myelodysplastic Syndromes--blood<br/>Pilot Projects<br/>Primary Myelofibrosis--blood<br/>Salvage Therapy<br/>Survival Analysis<br/>Survival Rate<br/>Thiotepa--administration & dosage<br/>Tissue Donors<br/>Transplantation, Homologous<br/>Treatment Outcome